Bethesda, Md., – The Parenteral Drug Association (PDA) is proud to present the second annual Pharmacopoeia Conference, at the Crown Plaza Geneva, Switzerland, May 16-17. This year’s event features lectures from representatives of the pharmacopoeias of:
- United States
Representatives from the World Health Organization and the UK’s Medicines & Healthcare Products Agency also will speak. Once again, the European Directorate for Quality of Medicines & Healthcare (EDQM) is chairing the conference.
Sessions will cover how pharmacopoeias function within their national regulatory frameworks, reference standards, manufacturing changes, and the convergence of standards. The conference will provide ample time for discussion, including a session for roundtable discussions of several important topics.
“Following the success of the inaugural Pharmacopoeia Conference in 2018, PDA is pleased to present this event,” said Richard Johnson, President and CEO, PDA. “PDA appreciates the work of the EDQM in supporting this meeting and providing leadership the planning committee.”
Representatives from pharmaceutical companies also are participating as podium presenters, including from: Johnson & Johnson, GSK, Pfizer, Novartis, Biogen, Novo Nordisk, Ely Lilly and Company, and Hoffmann-La Roche.
Members of the press are welcome to apply for a press pass.